Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
New York Times - Nov 17, 2026
Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.